Cargando…

Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold

Artificial intelligence (AI) is a broad term referring to any automated systems that need ‘intelligence’ to carry out specific tasks. During the last decade, AI-based techniques have been gaining popularity in a vast range of biomedical fields, including the cardiovascular setting. Indeed, the disse...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiarito, Mauro, Luceri, Luca, Oliva, Angelo, Stefanini, Giulio, Condorelli, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947926/
https://www.ncbi.nlm.nih.gov/pubmed/36845218
http://dx.doi.org/10.15420/ecr.2022.11
_version_ 1784892667310637056
author Chiarito, Mauro
Luceri, Luca
Oliva, Angelo
Stefanini, Giulio
Condorelli, Gianluigi
author_facet Chiarito, Mauro
Luceri, Luca
Oliva, Angelo
Stefanini, Giulio
Condorelli, Gianluigi
author_sort Chiarito, Mauro
collection PubMed
description Artificial intelligence (AI) is a broad term referring to any automated systems that need ‘intelligence’ to carry out specific tasks. During the last decade, AI-based techniques have been gaining popularity in a vast range of biomedical fields, including the cardiovascular setting. Indeed, the dissemination of cardiovascular risk factors and the better prognosis of patients experiencing cardiovascular events resulted in an increase in the prevalence of cardiovascular disease (CVD), eliciting the need for precise identification of patients at increased risk for development and progression of CVD. AI-based predictive models may overcome some of the limitations that hinder the performance of classic regression models. Nonetheless, the successful application of AI in this field requires knowledge of the potential pitfalls of the AI techniques, to guarantee their safe and effective use in daily clinical practice. The aim of the present review is to summarise the pros and cons of different AI methods and their potential application in the cardiovascular field, with a focus on the development of predictive models and risk assessment tools.
format Online
Article
Text
id pubmed-9947926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-99479262023-02-24 Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold Chiarito, Mauro Luceri, Luca Oliva, Angelo Stefanini, Giulio Condorelli, Gianluigi Eur Cardiol Risk Stratification and Biomarkers Artificial intelligence (AI) is a broad term referring to any automated systems that need ‘intelligence’ to carry out specific tasks. During the last decade, AI-based techniques have been gaining popularity in a vast range of biomedical fields, including the cardiovascular setting. Indeed, the dissemination of cardiovascular risk factors and the better prognosis of patients experiencing cardiovascular events resulted in an increase in the prevalence of cardiovascular disease (CVD), eliciting the need for precise identification of patients at increased risk for development and progression of CVD. AI-based predictive models may overcome some of the limitations that hinder the performance of classic regression models. Nonetheless, the successful application of AI in this field requires knowledge of the potential pitfalls of the AI techniques, to guarantee their safe and effective use in daily clinical practice. The aim of the present review is to summarise the pros and cons of different AI methods and their potential application in the cardiovascular field, with a focus on the development of predictive models and risk assessment tools. Radcliffe Cardiology 2022-12-20 /pmc/articles/PMC9947926/ /pubmed/36845218 http://dx.doi.org/10.15420/ecr.2022.11 Text en Copyright © 2022, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Risk Stratification and Biomarkers
Chiarito, Mauro
Luceri, Luca
Oliva, Angelo
Stefanini, Giulio
Condorelli, Gianluigi
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
title Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
title_full Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
title_fullStr Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
title_full_unstemmed Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
title_short Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
title_sort artificial intelligence and cardiovascular risk prediction: all that glitters is not gold
topic Risk Stratification and Biomarkers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947926/
https://www.ncbi.nlm.nih.gov/pubmed/36845218
http://dx.doi.org/10.15420/ecr.2022.11
work_keys_str_mv AT chiaritomauro artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold
AT luceriluca artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold
AT olivaangelo artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold
AT stefaninigiulio artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold
AT condorelligianluigi artificialintelligenceandcardiovascularriskpredictionallthatglittersisnotgold